CDE: Notice on Soliciting Opinions on measures for the administration of the disclosure of drug technology review information
-
Last Update: 2016-06-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2016-06-03 in order to standardize the disclosure of drug technology review information and further improve the quality and efficiency of work, our center drafted the measures for the administration of the disclosure of drug technology review information (Draft for comments), which is now open to the public for comments If there is any opinion from all walks of life, please give feedback by email before July 1, 2016 Contact: Huang Qingzhu e-mail: huangqzh@cde.org.cn administrative measures for the disclosure of drug technology review information (Draft for comments) issued by the drug review center of the State Food and Drug Administration on June 1, 2016 See the link: http:// Method = viewinfocommon & id = 313590
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
